-
2
-
-
0035154469
-
Hepatitis B - An important public health issue
-
Maddrey W.C. Hepatitis B - an important public health issue. Clin. Lab. 47(1-2):2001;51-55.
-
(2001)
Clin. Lab.
, vol.47
, Issue.1-2
, pp. 51-55
-
-
Maddrey, W.C.1
-
3
-
-
0036291076
-
Epidemiology, risk factors, and natural history of hepatocellular carcinoma
-
Montalto G., Cervello M., Giannitrapani L., Dantona F., Terranova A., Castagnetta L.A. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann. N.Y. Acad. Sci. 963:2002;13-20.
-
(2002)
Ann. N.Y. Acad. Sci.
, vol.963
, pp. 13-20
-
-
Montalto, G.1
Cervello, M.2
Giannitrapani, L.3
Dantona, F.4
Terranova, A.5
Castagnetta, L.A.6
-
4
-
-
0037099610
-
Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method
-
Iizuka N., Oka M., Yamada-Okabe H., Mori N., Tamesa T., Okada T.et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 15;62(14):2002;3939-3944.
-
(2002)
Cancer Res.
, vol.62
, Issue.14
, pp. 3939-3944
-
-
Iizuka, N.1
Oka, M.2
Yamada-Okabe, H.3
Mori, N.4
Tamesa, T.5
Okada, T.6
-
5
-
-
0027378724
-
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B
-
Wong D.K.H., Cheung A.M., O'Rourke K., Naylor C.D., Detsky A.S., Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. Ann. Intern. Med. 119:1993;312-323.
-
(1993)
Ann. Intern. Med.
, vol.119
, pp. 312-323
-
-
Wong, D.K.H.1
Cheung, A.M.2
O'Rourke, K.3
Naylor, C.D.4
Detsky, A.S.5
Heathcote, J.6
-
6
-
-
0036274159
-
Recent progress and new trends in the treatment of hepatitis B
-
Alberti A., Brunetto M.R., Colombo M., Craxi A. Recent progress and new trends in the treatment of hepatitis B. J. Med. Virol. 67(3):2002;458-462.
-
(2002)
J. Med. Virol.
, vol.67
, Issue.3
, pp. 458-462
-
-
Alberti, A.1
Brunetto, M.R.2
Colombo, M.3
Craxi, A.4
-
7
-
-
0036314982
-
Nucleoside analogues for chronic hepatitis B: Antiviral efficacy and viral resistance
-
Papatheodoridis G.V., Dimou E., Papadimitropoulos V. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. Am. J. Gastroenterol. 97(7):2002;1618-1628.
-
(2002)
Am. J. Gastroenterol.
, vol.97
, Issue.7
, pp. 1618-1628
-
-
Papatheodoridis, G.V.1
Dimou, E.2
Papadimitropoulos, V.3
-
8
-
-
0034769082
-
Interleukin-12 in the treatment of chronic hepatitis B and C
-
Zeuzem S., Carreno V. Interleukin-12 in the treatment of chronic hepatitis B and C. Antivir. Res. 52(2):2001;181-188.
-
(2001)
Antivir. Res.
, vol.52
, Issue.2
, pp. 181-188
-
-
Zeuzem, S.1
Carreno, V.2
-
9
-
-
0033552455
-
Chronic hepatitis B: New therapies on the horizon?
-
Pianko S., Mc Hutchinson J. Chronic hepatitis B: new therapies on the horizon? Lancet. 354:1999;1662-1663.
-
(1999)
Lancet
, vol.354
, pp. 1662-1663
-
-
Pianko, S.1
Mc Hutchinson, J.2
-
10
-
-
17744383748
-
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
-
Boni C., Penna A., Ogg G.S., Bertoletti A., Pilli M., Cavallo C.et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology. 33(4):2001;963-971.
-
(2001)
Hepatology
, vol.33
, Issue.4
, pp. 963-971
-
-
Boni, C.1
Penna, A.2
Ogg, G.S.3
Bertoletti, A.4
Pilli, M.5
Cavallo, C.6
-
11
-
-
0035525235
-
Treatment of chronic hepatitis B
-
Yuen M.F., Lai C.L. Treatment of chronic hepatitis B. Lancet, Infect. Dis. 1(4):2001 (Nov.);232-241.
-
(2001)
Lancet, Infect. Dis.
, vol.1
, Issue.4
, pp. 232-241
-
-
Yuen, M.F.1
Lai, C.L.2
-
12
-
-
0036096740
-
Management of patients with chronic hepatitis B
-
Liaw Y.F.J. Management of patients with chronic hepatitis B. Gastroenterol. Hepatol. 17(4):2002;406-408.
-
(2002)
Gastroenterol. Hepatol.
, vol.17
, Issue.4
, pp. 406-408
-
-
Liaw, Y.F.J.1
-
13
-
-
0036173630
-
Evolving therapies for the treatment of chronic hepatitis B virus infection
-
Locarnini S.A., Bartholomeusz A., Delaney W.E. Evolving therapies for the treatment of chronic hepatitis B virus infection. Expert Opin. Investig. Drugs. 11(2):2002;169-187.
-
(2002)
Expert Opin. Investig. Drugs
, vol.11
, Issue.2
, pp. 169-187
-
-
Locarnini, S.A.1
Bartholomeusz, A.2
Delaney, W.E.3
-
14
-
-
0030179606
-
Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B
-
Rasi G., Mutchnick M.G., Di Virgilio D., Sinibaldi-Vallebona P., Pierimarchi P., Colella F.et al. Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. J. Viral Hepat. 3(4):1996;191-196.
-
(1996)
J. Viral Hepat.
, vol.3
, Issue.4
, pp. 191-196
-
-
Rasi, G.1
Mutchnick, M.G.2
Di Virgilio, D.3
Sinibaldi-Vallebona, P.4
Pierimarchi, P.5
Colella, F.6
-
15
-
-
0036633685
-
Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase
-
Lau G.K., Nanji A., Hou J., Fong D.Y., Au W.S., Yuen S.T.et al. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. J. Viral Hepat. 9(4):2002;280-287.
-
(2002)
J. Viral Hepat.
, vol.9
, Issue.4
, pp. 280-287
-
-
Lau, G.K.1
Nanji, A.2
Hou, J.3
Fong, D.Y.4
Au, W.S.5
Yuen, S.T.6
-
16
-
-
0034596944
-
Natural killer T cell activation inhibits hepatitis B virus replication in vivo
-
Kakimi K., Guidotti L.G., Koezuka Y., Chisari F.V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192(7):2000;921-930.
-
(2000)
J. Exp. Med.
, vol.192
, Issue.7
, pp. 921-930
-
-
Kakimi, K.1
Guidotti, L.G.2
Koezuka, Y.3
Chisari, F.V.4
-
17
-
-
0036461318
-
Immunology of hepatitis B infection
-
Jung M.C., Pape G.R. Immunology of hepatitis B infection. Lancet Infect. Dis. 2(1):2002;43-50.
-
(2002)
Lancet Infect. Dis.
, vol.2
, Issue.1
, pp. 43-50
-
-
Jung, M.C.1
Pape, G.R.2
-
18
-
-
0036271116
-
Viral determinants and host immune responses in the pathogenesis of HBV infection
-
Rapicetta M., Ferrari C., Levrero M. Viral determinants and host immune responses in the pathogenesis of HBV infection. J. Med. Virol. 67(3):2002;454-457.
-
(2002)
J. Med. Virol.
, vol.67
, Issue.3
, pp. 454-457
-
-
Rapicetta, M.1
Ferrari, C.2
Levrero, M.3
-
19
-
-
0037080116
-
Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice
-
Gotsman I., Alper R., Klein A., Rabbani E., Engelhardt D., Ilan Y. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer. 15; 94(2):2002;406-414.
-
(2002)
Cancer
, vol.94
, Issue.2
, pp. 406-414
-
-
Gotsman, I.1
Alper, R.2
Klein, A.3
Rabbani, E.4
Engelhardt, D.5
Ilan, Y.6
-
20
-
-
0036131962
-
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice
-
Gotsman I., Israeli D., Alper R., Rabbani E., Engelhardt D., Ilan Y. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int. J. Cancer. 97(1):2002;52-57.
-
(2002)
Int. J. Cancer
, vol.97
, Issue.1
, pp. 52-57
-
-
Gotsman, I.1
Israeli, D.2
Alper, R.3
Rabbani, E.4
Engelhardt, D.5
Ilan, Y.6
-
21
-
-
0037905334
-
Thymalfasin up-regulates tumor antigen expression in colorectal cancer cells
-
[suppl., S1Abs O-55]
-
Sinibaldi-Vallebona P., Pierimarchi P., Moroni G., Serafino A., Tuthill C., Rasi G. Thymalfasin up-regulates tumor antigen expression in colorectal cancer cells. Tumor Biol. 23:2002;45. [suppl., S1Abs O-55].
-
(2002)
Tumor Biol.
, vol.23
, pp. 45
-
-
Sinibaldi-Vallebona, P.1
Pierimarchi, P.2
Moroni, G.3
Serafino, A.4
Tuthill, C.5
Rasi, G.6
-
22
-
-
0033621845
-
Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level
-
Giuliani C., Napolitano G., Mastino A., Di Vincenzo S., D'Agostini C., Grelli S.et al. Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level. Eur. J. Immunol. 30(3):2000;778-786.
-
(2000)
Eur. J. Immunol.
, vol.30
, Issue.3
, pp. 778-786
-
-
Giuliani, C.1
Napolitano, G.2
Mastino, A.3
Di Vincenzo, S.4
D'Agostini, C.5
Grelli, S.6
-
23
-
-
0031888375
-
Gasbarrini Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: A preliminary experience
-
Stefanini G.F., Foschi F.G., Castelli E., Marsigli L., Biselli M., Mucci F.et al. Gasbarrini Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience. G. Hepatogastroenterol. 45(19):1998;209-215.
-
(1998)
G. Hepatogastroenterol.
, vol.45
, Issue.19
, pp. 209-215
-
-
Stefanini, G.F.1
Foschi, F.G.2
Castelli, E.3
Marsigli, L.4
Biselli, M.5
Mucci, F.6
-
24
-
-
0038581511
-
Thr Royal College of Physicians of London and the British Society of Gastroenterology. Clinical guidelines on the management of hepatitis C
-
Booth J.C., O'Grady J., Neuberger J. Thr Royal College of Physicians of London and the British Society of Gastroenterology. Clinical guidelines on the management of hepatitis C. Gut. 49(Suppl 1):2001;11-21.
-
(2001)
Gut
, vol.49
, Issue.SUPPL. 1
, pp. 11-21
-
-
Booth, J.C.1
O'Grady, J.2
Neuberger, J.3
-
25
-
-
0037133079
-
Surprisingly small effect of antiviral treatment in patients with hepatitis C
-
Falck-Ytter Y., Kale H., Mullen K.D., Sarbah S.A., Sorescu L., McCullough A.J. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann. Intern. Med. 136(4):2002;288-292.
-
(2002)
Ann. Intern. Med.
, vol.136
, Issue.4
, pp. 288-292
-
-
Falck-Ytter, Y.1
Kale, H.2
Mullen, K.D.3
Sarbah, S.A.4
Sorescu, L.5
McCullough, A.J.6
-
26
-
-
0029833829
-
Meta-analysis of Interferon randomised trials in the treatment of viral hepatitis C: Effects of dose and duration
-
Poynard T., Leroy V., Cohard M., Thevenot T., Mathurin P., Opolon P.et al. Meta-analysis of Interferon randomised trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology. 24:1996;778-789.
-
(1996)
Hepatology
, vol.24
, pp. 778-789
-
-
Poynard, T.1
Leroy, V.2
Cohard, M.3
Thevenot, T.4
Mathurin, P.5
Opolon, P.6
-
28
-
-
0026733674
-
A pilot study of ribavirin therapy for chronic hepatitis C
-
Di Bisceglie A., Shindo M., Fong T.-L., Frier M., Swain M., Berlasa N.et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology. 16:1994;649-654.
-
(1994)
Hepatology
, vol.16
, pp. 649-654
-
-
Di Bisceglie, A.1
Shindo, M.2
Fong, T.-L.3
Frier, M.4
Swain, M.5
Berlasa, N.6
-
29
-
-
0028825313
-
Ribavirin as monotherapy for chronic hepatitis C: A randomised, double-blind, placebo-controlled trial
-
Di Bisceglie A., Conjeevaram H., Fried M., Sallie R., Park Y., Yurdayin C.et al. Ribavirin as monotherapy for chronic hepatitis C: a randomised, double-blind, placebo-controlled trial. Ann. Intern. Med. 123:1995;897-903.
-
(1995)
Ann. Intern. Med.
, vol.123
, pp. 897-903
-
-
Di Bisceglie, A.1
Conjeevaram, H.2
Fried, M.3
Sallie, R.4
Park, Y.5
Yurdayin, C.6
-
30
-
-
10344259671
-
Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study
-
Dusheiko G., Main J., Thomas H., Reichard O., Lee C., Dhillon A.et al. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J. Hepatol. 25:1996;591-598.
-
(1996)
J. Hepatol.
, vol.25
, pp. 591-598
-
-
Dusheiko, G.1
Main, J.2
Thomas, H.3
Reichard, O.4
Lee, C.5
Dhillon, A.6
-
31
-
-
0032585237
-
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. International Hepatitis Interventional Therapy Group [IHIT]
-
Poynard T., Marcellin P., Lee S., Niederau C., Minuk G., Bain V.et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. International Hepatitis Interventional Therapy Group [IHIT]. Lancet. 352:1998;1426-1432.
-
(1998)
Lancet
, vol.352
, pp. 1426-1432
-
-
Poynard, T.1
Marcellin, P.2
Lee, S.3
Niederau, C.4
Minuk, G.5
Bain, V.6
-
32
-
-
0032547938
-
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
-
McHutchison J., Gordon S., Schiff E., Shiffman M., Lee W., Rustgi V.et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New Engl. J. Med. 339:1998;1485-1492.
-
(1998)
New Engl. J. Med.
, vol.339
, pp. 1485-1492
-
-
McHutchison, J.1
Gordon, S.2
Schiff, E.3
Shiffman, M.4
Lee, W.5
Rustgi, V.6
-
33
-
-
85046113016
-
Combination thymosin α1 and lymphoblastoid interferon treatment in chronic hepatitis C
-
Rasi G., Mutchnick M.G., Di Virgilio D., Pierimarchi P., Sinibaldi-Vallebona P., Colella F., Garaci E. Combination thymosin α1 and lymphoblastoid interferon treatment in chronic hepatitis C. Gut. 39:1996;670-683.
-
(1996)
Gut
, vol.39
, pp. 670-683
-
-
Rasi, G.1
Mutchnick, M.G.2
Di Virgilio, D.3
Pierimarchi, P.4
Sinibaldi-Vallebona, P.5
Colella, F.6
Garaci, E.7
-
34
-
-
0031752774
-
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: Preliminary results
-
Moscarella S., Buzzelli G., Romanelli R.G., Monti M., Giannini C., Careccia G.et al. Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results. Liver. 18(5):1998;366-369.
-
(1998)
Liver
, vol.18
, Issue.5
, pp. 366-369
-
-
Moscarella, S.1
Buzzelli, G.2
Romanelli, R.G.3
Monti, M.4
Giannini, C.5
Careccia, G.6
-
35
-
-
17344368726
-
Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial
-
Sherman K.E., Sjogren M., Creager R.L., Damiano M.A., Freeman S., Lewey S., Davis D., Root S., Weber F.L., Ishak K.G., Goodman Z.D. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Hepatology. 27(4):1998;1128-1135.
-
(1998)
Hepatology
, vol.27
, Issue.4
, pp. 1128-1135
-
-
Sherman, K.E.1
Sjogren, M.2
Creager, R.L.3
Damiano, M.A.4
Freeman, S.5
Lewey, S.6
Davis, D.7
Root, S.8
Weber, F.L.9
Ishak, K.G.10
Goodman, Z.D.11
-
36
-
-
0001623914
-
Interferon plus thymosin α-1 treatment of chronic hepatitis C infection: A meta-analysis
-
R. Schinazi, J. Sommadossi, & H. Thomas. London: International Medical Press
-
Sherman K., Sherman S. Interferon plus thymosin α-1 treatment of chronic hepatitis C infection: a meta-analysis. Schinazi R., Sommadossi J., Thomas H. Therapies for viral hepatitis. 1998;379-383 International Medical Press, London.
-
(1998)
Therapies for viral hepatitis
, pp. 379-383
-
-
Sherman, K.1
Sherman, S.2
-
37
-
-
0035016143
-
Cytokines and chemokines in the immune response to hepatitis C infection
-
Heydtmann M., Shields P., McCaughan G., Adams D. Cytokines and chemokines in the immune response to hepatitis C infection. Curr Opin Infect Dis. 14(3):2001;279-287.
-
(2001)
Curr Opin Infect Dis
, vol.14
, Issue.3
, pp. 279-287
-
-
Heydtmann, M.1
Shields, P.2
McCaughan, G.3
Adams, D.4
-
38
-
-
0036237490
-
Abnormal priming of CD4[+] T cells by dendritic cells expressing hepatitis C virus core and E1 proteins
-
[2001]
-
Sarobe P., Lasarte J.J., Casares N., Lopez-Diaz de Cerio A., Baixeras E., Labarga P.et al. Abnormal priming of CD4[+] T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76(10):2002;5062-5070. [2001].
-
(2002)
J. Virol.
, vol.76
, Issue.10
, pp. 5062-5070
-
-
Sarobe, P.1
Lasarte, J.J.2
Casares, N.3
Lopez-Diaz de Cerio, A.4
Baixeras, E.5
Labarga, P.6
-
39
-
-
0037033359
-
Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein
-
Crotta S., Stilla A., Wack A., D'Andrea A., Nuti S., D'Oro U.et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 7;195(1):2002;35-41.
-
(2002)
J. Exp. Med.
, vol.195
, Issue.1
, pp. 35-41
-
-
Crotta, S.1
Stilla, A.2
Wack, A.3
D'Andrea, A.4
Nuti, S.5
D'Oro, U.6
-
40
-
-
0036139684
-
Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: Correlation with clinical disease stages
-
Rosen H.R., Miner C., Sasaki A.W., Lewinsohn D.M., Conrad A.J., Bakke A.et al. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages. Hepatology. 35(1):2002;190-198.
-
(2002)
Hepatology
, vol.35
, Issue.1
, pp. 190-198
-
-
Rosen, H.R.1
Miner, C.2
Sasaki, A.W.3
Lewinsohn, D.M.4
Conrad, A.J.5
Bakke, A.6
-
41
-
-
0036280695
-
HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C
-
Woitas R.P., Petersen U., Moshage D., Brackmann H.H., Matz B., Sauerbruch T.et al. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World J. Gastroenterol. 8(3):2002;562-566.
-
(2002)
World J. Gastroenterol.
, vol.8
, Issue.3
, pp. 562-566
-
-
Woitas, R.P.1
Petersen, U.2
Moshage, D.3
Brackmann, H.H.4
Matz, B.5
Sauerbruch, T.6
-
42
-
-
0036250072
-
Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-alpha/ribavirin
-
Amati L., Caradonna L., Magrone T., Mastronardi M.L., Cuppone R., Cozzolongo R.et al. Modifications of the immune responsiveness in patients with hepatitis C virus infection following treatment with IFN-alpha/ribavirin. Curr. Pharm. Des. 8(11):2002;981-993.
-
(2002)
Curr. Pharm. Des.
, vol.8
, Issue.11
, pp. 981-993
-
-
Amati, L.1
Caradonna, L.2
Magrone, T.3
Mastronardi, M.L.4
Cuppone, R.5
Cozzolongo, R.6
-
43
-
-
0037086525
-
CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons
-
MacDonald A.J., Duffy M., Brady M.T., McKiernan S., Hall W., Hegarty J.et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 15;185(6):2002;720-727.
-
(2002)
J. Infect. Dis.
, vol.185
, Issue.6
, pp. 720-727
-
-
MacDonald, A.J.1
Duffy, M.2
Brady, M.T.3
McKiernan, S.4
Hall, W.5
Hegarty, J.6
-
44
-
-
0034982919
-
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C
-
Andreone P., Cursaro C., Gramenzi A., Margotti M., Ferri E., Talarico S.et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. J. Viral Hepatitis. 8(3):2001;194-201.
-
(2001)
J. Viral Hepatitis
, vol.8
, Issue.3
, pp. 194-201
-
-
Andreone, P.1
Cursaro, C.2
Gramenzi, A.3
Margotti, M.4
Ferri, E.5
Talarico, S.6
-
45
-
-
0038242780
-
Ameta-analysis of thymosin-A1 treatment in chronic hepatitis B virus (HBV) infection
-
Chan H. Ameta-analysis of thymosin-A1 treatment in chronic hepatitis B virus (HBV) infection. J. Hepatol. 34:2001;133.
-
(2001)
J. Hepatol.
, vol.34
, pp. 133
-
-
Chan, H.1
|